CYCLOSPORINE

  • Role of cyclosporine in glomerular diseases
    Richard J. Glassock, MD
    Cleveland Clinic Journal of Medicine September 1994, 61 (5) 363-369;

    Cyclosporine shows promise in renal disease, but randomized, controlled trials are needed to better define how and when to use it.

  • Cyclosporine: mechanisms of action and toxicity
    Robert M. Graham, MD
    Cleveland Clinic Journal of Medicine July 1994, 61 (4) 308-313;
  • Azathioprine vs cyclosporine in recipients of HLA-identical renal allografts
    Inderbir S. Gill, MD, Ernest E. Hodge, MD, Andrew C. Novick, MD, Stevan B. Streem, MD, William E. Braun, MD and Lata Paranandi, MSHP
    Cleveland Clinic Journal of Medicine May 1994, 61 (3) 206-210;

    These two agents produce equally satisfactory outcomes in this immunologically favored group. The need for continued steroid therapy in these patients requires further study.